E-leviate joins Clare Ventures Portfolio

Clare Ventures is proud to announce our investment in E-Leviate, through Outset Ventures, signaling a big step forward for this incredible company which is tackling some of the most common yet underserved conditions in women’s health.

Conditions like pelvic organ prolapse and genitourinary syndrome of menopause affect millions of women globally, yet treatment options today are often uncomfortable, inconvenient, or require repeated clinical intervention. Despite the scale of the problem, innovation in this space has historically been limited. E-Leviate is developing a device designed to combine structural support with sustained local estrogen delivery, aiming to make treatment simpler and more effective.

Women’s health has long been underfunded relative to its impact. Companies like E-Leviate are helping change that. Founded by Dr. Prathima Chowdary, E-Leviate is developing this exact novel drug-device combination providing both structural support and therapeutic delivery in a single integrated solution.